Lyra Therapeutics, Inc. (LYRA) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $36.11M | -45.6% |
| 2024 | $66.35M | -53.5% |
| 2023 | $142.60M | +29.7% |
| 2022 | $109.97M | +100.4% |
| 2021 | $54.87M | -32.1% |
| 2020 | $80.83M | +440.2% |
| 2019 | $14.96M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $36.11M | -45.6% |
| 2024 | $66.35M | -53.5% |
| 2023 | $142.60M | +29.7% |
| 2022 | $109.97M | +100.4% |
| 2021 | $54.87M | -32.1% |
| 2020 | $80.83M | +440.2% |
| 2019 | $14.96M | — |